Market Insight – Putting the brakes on burn rate
This article was originally published in Scrip
Executive Summary
The latest data indicate that a worrying number of biotech firms are teetering on the brink of bankruptcy. Time to hit the panic button or to revisit your operational plan? Chad Nikel explains